IntegenX this week announced the appointment of Robert Schueren as CEO.
Schueren most recently served as vice president and general manager of genomics for Agilent Technologies. Prior to joining Agilent in 2010, he was the global head of clinical biomarkers and operations and deputy global head of molecular medicine labs at Genentech. Schueren also served as senior director of development sciences and director of companion diagnostics at Genentech. Schueren has also served as executive vice president and COO of Arcturus Bioscience; and has worked for Accumetrics, Biosite Diagnostics, and Gen-Probe (now Hologic).
Stevan Jovanovich, a founder and past president and CEO of IntegenX, will remain with the company as chief technology officer.
Applied BioCode said this week that it has appointed Michael Aye as vice president of molecular products.
Aye has previously been employed by Focus Diagnostics and Beckman Coulter. Prior to his industrial experience, he spent 10 years in academia focused on research in molecular genetics and microbiology.
Aye obtained a BS in microbiology in 1995 from California State University, Long Beach, and PhD in biology (molecular genetics) in 2001 from the University of California, Irvine.